PCI 3.06.26

Current Edition

Current Features

Subsection - Neurodegenerative Diseases

From Depression to Deep-Learning: Leveraging iPSC and AI Platforms for Evidence-Based Depression Treatment

Continue reading

Subsection - Oncology

Essential DMPK Strategies for IND Success

Continue reading

Subsection - Cell and Gene Therapy

When the Gene Editing Guide is the Drug

Continue reading

Upcoming Events

CPHI 2027
AI in Drug Discovery
DDL 2026
Biotechnology Show 13.02.26

Advertisement

Advertisement

A&M Stabtest April 26

Advertisement

Biopharma Group – 19th March 2025

Advertisement

Micron View

Advertisement

Bachem skyscraper

Advertisement

Fujifilm
news

Novartis suspends production of two radiopharmaceutical drugs over quality concerns

Dive Brief: Novartis has suspended production of two cancer drugs at plants in Italy and New Jersey due to “potential quality issues” it identified in its manufact...
Continue Reading →
news

Novartis names longtime analyst as top dealmaker amid organizational shakeup

Dive Brief: Novartis on Tuesday named Ronny Gal, a longtime analyst with advisory firm Bernstein, as its chief strategy and growth officer, the latest move in an o...
Continue Reading →
news

FDA sets back Novartis’ best chance at a COVID-19 drug

Dive Brief: Novartis is reevaluating its commitment to an experimental COVID-19 treatment originally developed by fellow Swiss drug company Molecular Partners afte...
Continue Reading →
news

Novartis breast cancer drug approved for ultra-rare condition

Dive Brief: The Food and Drug Administration has approved the first drug to treat an ultra-rare cluster of conditions caused by mutations in a specific gene, grant...
Continue Reading →
news

Novartis wins FDA OK for radiopharmaceutical drug, cashing in on Endocyte deal

Dive Brief: Novartis has won Food and Drug Administration approval to sell a radiopharmaceutical designed to treat a form of advanced prostate cancer in a key step...
Continue Reading →
news

Novartis turns cell therapy skill into contract manufacturing deal

Dive Brief: Novartis will manufacture an experimental cancer cell therapy for the small Philadelphia-based Carisma Therapeutics in a deal that marks another early ...
Continue Reading →
news

Third Harmonic, led by former Audentes CEO, launches with $155M in funding

Third Harmonic Bio, a biotech startup founded in 2019 by Atlas Venture, officially launched on Wednesday with $105 million in new funding to advance development of an...
Continue Reading →
news

Novartis ups investment in gene therapy for the eye with $800M buyout

Novartis' offer comes three months after Gyroscope presented at a medical meeting early data from 13 patients who had been dosed with the gene therapy, called GT005, ...
Continue Reading →
news

Novartis wins FDA approval for new heart drug, but faces uphill sales battle

Leqvio arrives with high sales expectations, but uptake could be slow as insurers and doctors weigh the drug's safety and cost-effectiveness. Novartis on Wednesday w...
Continue Reading →
news

Lilly pours more money into genetic treatments for neurological diseases

With its potential to treat an enormous range of diseases, genetic medicine has become a focal point for many large drug companies. Novartis, for instance, just last ...
Continue Reading →

Advertisement

Richter: Wed 23 October 2024, 09:03

Advertisement

Aseptic Tech

Advertisement

Steribar – 12.05.2025

Advertisement

PharmExcel

Advertisement

Polypure hompage

Advertisement

Gen Xpro

Advertisement

Alphinity

Advertisement

Crown Bioscience

Advertisement

Shimadzu

Advertisement

CPC